Institutional & Tender Business
Our core business. Direct tender bidding and supply through pharmaceutical partners. Active on eSupply/Jaggaer, with MoF/EHS, Rafed and ADGPG in registration.
Pharma, built by operators
Emirates Drug Establishment licensed. Importer, wholesaler and tender supplier of medicines and medical devices in the UAE.
Value chain
Seven steps carry a medicine from formulation to a hospital shelf. QANTARIS runs the five that follow registration under its own Emirates Drug Establishment licence, and coordinates development and manufacturing through European partners.
Formulation and development of essential therapies, scoped with European development partners against the demand we see in the market.
European dossiers prepared and submitted for UAE marketing authorisation, and carried through Emirates Drug Establishment review.
Regulatory affairsProduction at EU-GMP manufacturing sites in Europe, held to the release and quality standards the dossier was built on.
Import, storage and onward distribution under our Emirates Drug Establishment Medical Warehouse classification, cold chain included.
Wholesale & distributionCommercialisation of partner portfolios in the UAE, across institutional and commercial channels.
In-licensing and out-licensing built on a dossier library of 410 molecules across 810 variants, taken from agreement to market.
Browse the libraryOur core business. Direct tender bidding and supply to health authorities and hospital groups, active on eSupply/Jaggaer.
Institutional & tenderScope of activity
QANTARIS operates across the full route to market in the UAE, from European dossier to institutional tender.
Our core business. Direct tender bidding and supply through pharmaceutical partners. Active on eSupply/Jaggaer, with MoF/EHS, Rafed and ADGPG in registration.
Licensed import, storage and distribution of medicines and medical devices in the UAE under our Emirates Drug Establishment Medical Warehouse classification.
Taking European dossiers through UAE marketing authorisation: submission preparation, technical review, and registration follow-through with the Emirates Drug Establishment.
A dossier library of 410 molecules across 810 variants, used to identify in-licensing opportunities and take partner portfolios from agreement to market.

Founder
QANTARIS is led by Paulo Paiva dos Santos, the pharmaceutical entrepreneur who founded Generis in 2002 and grew it into Portugal’s largest generic pharmaceutical company.
A Harvard Business School and Oxford alumnus, Paulo scaled Generis from start-up to industrial powerhouse before its acquisition by the Aurobindo group. Today he is based in Dubai, where he serves as President of the Portuguese Business Council, established by Dubai Chambers.
The Paulo & Generis storyReady to begin?
Talk to us about registering, importing and distributing your portfolio in the UAE, or browse the dossier library for in-licensing opportunities.